Strategic Growth PreOmics is now part of the Biognosys Group, expanding access to multiomics workflows and enabling cross-sell opportunities across proteomics, metabolomics, and lipidomics solutions.

Automation Opportunity Recent product launches such as PreON robotic automation and BeatBox FFPE workflow indicate a strong aperture for selling integrated automation, sample prep consumables, and workflow optimization services to labs seeking throughput gains.

Advanced Kits ENRICH-iST kits for enriching low-abundance plasma and serum proteins present a clear entry point for upselling targeted proteomics workflows to labs focusing on biomarker discovery and clinical research.

Enterprise Readiness With ISO 9001 certification and integration capabilities across SCIEX, SAP S/4HANA, and Webflow, there is potential to offer scalable procurement, compliance-friendly solutions, and enterprise-grade support to larger lab networks.

Financial Levers Bruker-backed funding history and revenue growth signals provide momentum for co-developed or co-marketed offerings within the Biognosys Group, enabling joint go-to-market strategies and higher-value deals.